Defibrotide in Children With High Risk Kawasaki Disease

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05911386` - Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases
Recruiting	`NCT02951234` - A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease	N/A
Active, not recruiting	`NCT02853266` - Measurement of Antibodies in Adults With a History of Kawasaki Disease	N/A
Active, not recruiting	`NCT04747847` - Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease	Early Phase 1
Withdrawn	`NCT04535518` - Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease	Phase 3
Recruiting	`NCT01917721` - Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease	Phase 2
Recruiting	`NCT04656184` - A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment	Phase 3
Recruiting	`NCT03200561` - A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)	Phase 3
Completed	`NCT01440075` - Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease	N/A
Completed	`NCT02179853` - Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease	Phase 1/Phase 2
Withdrawn	`NCT02980263` - Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease	Phase 2
Enrolling by invitation	`NCT02359643` - Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease	N/A
Recruiting	`NCT04278404` - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Completed	`NCT00760435` - Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease	Phase 3
Completed	`NCT00841789` - A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease	Phase 2
Not yet recruiting	`NCT05643651` - Rivaroxaban for Children With Giant Coronary Artery Aneurysms After Kawasaki Disease	Phase 4
Recruiting	`NCT02114099` - Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease	Phase 2
Not yet recruiting	`NCT05091229` - A Blood Test to Diagnose Kawasaki Disease
Completed	`NCT01431105` - Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities	Phase 1/Phase 2
Recruiting	`NCT01793168` - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT number	NCT04777422
Study type	Interventional
Source	New York Medical College
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	February 24, 2021
Completion date	June 2024

Defibrotide in Children With High Risk Kawasaki Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms